Nurix Therapeutics, Inc. · NASDAQ:NRIX
Vestal Point Capital, LP reported a 7.80% stake in Nurix Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vestal Point Capital, LP reported a 7.80% stake in Nurix Therapeutics, Inc., 8,050,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 8,050,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 7.80% | 8,050,000 |
| Ryan Wilder | 7.80% | 8,050,000 |
Source
Related
- Nurix Therapeutics, Inc.
- Vestal Point Capital, LP
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Form 4 · Ring Christine · Oct 2, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Ring Christine · Sep 2, 2026